The DOI matches its Crossref record; 31 of the 35 references it cites were found in a registry or an index; none of the 10 sources its claims cite is checked for support yet.
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
Open accessPublished version of a preprint
Abstract
BACKGROUND: Neurological and psychiatric sequelae of COVID-19 have been reported, but more data are needed to adequately assess the effects of COVID-19 on brain health. We aimed to provide robust estimates of incidence rates and relative risks of neurological and psychiatric diagnoses in patients in the 6 months following a COVID-19 diagnosis. METHODS: For this retrospective cohort study and time-to-event analysis, we used data obtained from the TriNetX electronic health records network (with over 81 million patients). Our primary cohort comprised patients who had a COVID-19 diagnosis; one matched control cohort included patients diagnosed with influenza, and the other matched control cohort included patients diagnosed with any respiratory tract infection including influenza in the same period. Patients with a diagnosis of COVID-19 or a positive test for SARS-CoV-2 were excluded from the control cohorts. All cohorts included patients older than 10 years who had an index event on or after Jan 20, 2020, and who were still alive on Dec 13, 2020. We estimated the incidence of 14 neurological and psychiatric outcomes in the 6 months after a confirmed diagnosis of COVID-19: intracranial haemorrhage; ischaemic stroke; parkinsonism; Guillain-Barré syndrome; nerve, nerve root, and plexus disorders; myoneural junction and muscle disease; encephalitis; dementia; psychotic, mood, and anxiety disorders (grouped and separately); substance use disorder; and insomnia. Using a Cox model, we compared incidences with those in propensity score-matched cohorts of patients with influenza or other respiratory tract infections. We investigated how these estimates were affected by COVID-19 severity, as proxied by hospitalisation, intensive therapy unit (ITU) admission, and encephalopathy (delirium and related disorders). We assessed the robustness of the differences in outcomes between cohorts by repeating the analysis in different scenarios. To provide benchmarking for the incidence and risk of neurological and psychiatric sequelae, we compared our primary cohort with four cohorts of patients diagnosed in the same period with additional index events: skin infection, urolithiasis, fracture of a large bone, and pulmonary embolism. FINDINGS: Among 236 379 patients diagnosed with COVID-19, the estimated incidence of a neurological or psychiatric diagnosis in the following 6 months was 33·62% (95% CI 33·17-34·07), with 12·84% (12·36-13·33) receiving their first such diagnosis. For patients who had been admitted to an ITU, the estimated incidence of a diagnosis was 46·42% (44·78-48·09) and for a first diagnosis was 25·79% (23·50-28·25). Regarding individual diagnoses of the study outcomes, the whole COVID-19 cohort had estimated incidences of 0·56% (0·50-0·63) for intracranial haemorrhage, 2·10% (1·97-2·23) for ischaemic stroke, 0·11% (0·08-0·14) for parkinsonism, 0·67% (0·59-0·75) for dementia, 17·39% (17·04-17·74) for anxiety disorder, and 1·40% (1·30-1·51) for psychotic disorder, among others. In the group with ITU admission, estimated incidences were 2·66% (2·24-3·16) for intracranial haemorrhage, 6·92% (6·17-7·76) for ischaemic stroke, 0·26% (0·15-0·45) for parkinsonism, 1·74% (1·31-2·30) for dementia, 19·15% (17·90-20·48) for anxiety disorder, and 2·77% (2·31-3·33) for psychotic disorder. Most diagnostic categories were more common in patients who had COVID-19 than in those who had influenza (hazard ratio [HR] 1·44, 95% CI 1·40-1·47, for any diagnosis; 1·78, 1·68-1·89, for any first diagnosis) and those who had other respiratory tract infections (1·16, 1·14-1·17, for any diagnosis; 1·32, 1·27-1·36, for any first diagnosis). As with incidences, HRs were higher in patients who had more severe COVID-19 (eg, those admitted to ITU compared with those who were not: 1·58, 1·50-1·67, for any diagnosis; 2·87, 2·45-3·35, for any first diagnosis). Results were robust to various sensitivity analyses and benchmarking against the four additional index health events. INTERPRETATION: Our study provides evidence for substantial neurological and psychiatric morbidity in the 6 months after COVID-19 infection. Risks were greatest in, but not limited to, patients who had severe COVID-19. This information could help in service planning and identification of research priorities. Complementary study designs, including prospective cohorts, are needed to corroborate and explain these findings. FUNDING: National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In a retrospective cohort of 236,379 COVID-19 survivors, 33.62% received a neurological or psychiatric diagnosis within 6 months, and 12.84% received a first such diagnosis. Risks were higher than after influenza or other respiratory tract infections and were greatest in patients with more severe COVID-19, including ITU admission or encephalopathy.
Key findings
- Among 236,379 patients with COVID-19, the estimated 6-month incidence of any neurological or psychiatric diagnosis was 33.62% (95% CI 33.17–34.07), and of any first diagnosis was 12.84% (12.36–13.33). For ITU-admitted patients, these were 46.42% (44.78–48.09) and 25.79% (23.50–28.25); for patients with encephalopathy, 62.34% (60.14–64.55) and 31.13% (27.29–35.36).
- Individual 6-month incidences in the whole COVID-19 cohort included anxiety disorder 17.39% (17.04–17.74), mood disorder 13.66% (13.35–13.99), psychotic disorder 1.40% (1.30–1.51), ischaemic stroke 2.10% (1.97–2.23), intracranial haemorrhage 0.56% (0.50–0.63), dementia 0.67% (0.59–0.75), and parkinsonism 0.11% (0.08–0.14).
- Compared with influenza, COVID-19 was associated with higher risk of any diagnosis (HR 1.44, 95% CI 1.40–1.47) and any first diagnosis (1.78, 1.68–1.89); compared with other respiratory tract infections, HRs were 1.16 (1.14–1.17) and 1.32 (1.27–1.36), respectively. ITU admission versus no ITU admission was associated with HR 1.58 (1.50–1.67) for any diagnosis and 2.87 (2.45–3.35) for any first diagnosis.
- Most diagnostic categories were more common after COVID-19 than after influenza, except parkinsonism and Guillain-Barré syndrome, for which HRs were not significantly greater than 1 versus influenza.
Methods
- Retrospective cohort and time-to-event analysis using the TriNetX electronic health records network (over 81 million patients, 62 health-care organisations, primarily USA). The primary cohort had confirmed COVID-19 (ICD-10 U07.1); control cohorts had influenza or any respiratory tract infection including influenza, with COVID-19/SARS-CoV-2-positive patients excluded. All cohorts included patients older than 10 years with an index event on or after Jan 20, 2020, alive on Dec 13, 2020.
- Fourteen neurological and psychiatric outcomes were assessed 1–180 days after the index event, with first versus any diagnoses estimated depending on whether outcomes were chronic or recurrent. Cohorts were propensity-score matched 1:1 on 55 variables; incidence was estimated with Kaplan-Meier, comparisons with log-rank tests, and hazard ratios with Cox proportional hazards models.
- Secondary analyses examined COVID-19 severity via hospitalisation, ITU admission, and encephalopathy, with matched comparisons; sensitivity analyses included patients who died, test-confirmed COVID-19, and pre-pandemic influenza comparisons, plus benchmarking against four additional index events.
Limitations
- The paper states limitations inherent to electronic health records: unknown completeness of records, no validation of diagnoses, and sparse information on socioeconomic and lifestyle factors. It also notes that the choice of comparator cohort influenced hazard ratio magnitude, that encephalopathy was likely under-recorded and results should not be generalised to all patients with delirium, that timing differences and undiagnosed COVID-19 in controls likely made HRs underestimates, and that the study can only show associations, not causality.
- Evident from the text: despite propensity-score matching, residual confounding may remain; diagnoses rely on ICD-10 codes; and follow-up is limited to 6 months, so longer-term trajectories and duration of risk are not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
61 Own result · 12 Own interpretation · 8 Not checked yet · 8 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For a first diagnosis, the HRs were 1·83 (1·71–1·96) versus patients who had influenza and 1·28 (1·23–1·33) versus those who had other respiratory tract infections.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
- Rests on an assumption: The propensity score matching adequately controls for confounding by measured covariates.
- Rests on an assumption: The comparator cohorts (influenza and other respiratory tract infections) are appropriate to estimate the excess risk attributable to COVID-19.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“with a HR of 1·58 (1·50–1·67) for any diagnosis and 2·87 (2·45–3·35) for any first diagnosis (table 5, appendix p 22).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plaincorrelationaln = 8,942- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
- Rests on an assumption: The propensity score matching adequately controls for confounding by measured covariates.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Among 236 379 patients diagnosed with COVID-19, the estimated incidence of a neurological or psychiatric diagnosis in the following 6 months was 33·62% (95% CI 33·17–34·07), with 12·84% (12·36–13·33) receiving their first such diagnosis.”
- Also stated in: § Results · plain
“In the whole cohort, 33·62% (95% CI 33·17–34·07) of patients received a diagnosis (table 2).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Abstract > Findings
plainn = 379- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the group with ITU admission, estimated incidences were 2·66% (2·24–3·16) for intracranial haemorrhage, 6·92% (6·17–7·76) for ischaemic stroke, 0·26% (0·15–0·45) for parkinsonism, 1·74% (1·31–2·30) for dementia, 19·15% (17·90–20·48) for anxiety disorder, and 2·77% (2·31–3·33) for psychotic disorder.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Abstract > Findings
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This comparison showed greater hazard rates for all outcomes in the hospitalised group than in the non-hospitalised group, except for nerve, nerve root, or plexus disorders (table 5, figure 2), with an overall HR of 1·33 (1·29–1·37) for any diagnosis and 1·70 (1·56–1·86) for any first diagnosis.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plaincorrelationaln = 927- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
- Rests on an assumption: The propensity score matching adequately controls for confounding by measured covariates.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the group with ITU admission, estimated incidences were 2·66% (2·24–3·16) for intracranial haemorrhage, 6·92% (6·17–7·76) for ischaemic stroke, 0·26% (0·15–0·45) for parkinsonism, 1·74% (1·31–2·30) for dementia, 19·15% (17·90–20·48) for anxiety disorder, and 2·77% (2·31–3·33) for psychotic disorder.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Abstract > Findings
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Any first outcome | 1·78 (1·68–1·89) | <0·0001 | 1·32 (1·27–1·36) | <0·0001 |”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
- Rests on an assumption: The comparator cohorts (influenza and other respiratory tract infections) are appropriate to estimate the excess risk attributable to COVID-19.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“HRs remained significantly greater than 1 in this subgroup, with an overall HR for any diagnosis of 1·47 (95% CI 1·44–1·51) for patients who had COVID-19 compared with patients who had influenza, and 1·16 (1·14–1·17) compared with those who had other respiratory tract infections”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
- Rests on an assumption: The propensity score matching adequately controls for confounding by measured covariates.
- Rests on an assumption: The comparator cohorts (influenza and other respiratory tract infections) are appropriate to estimate the excess risk attributable to COVID-19.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our primary cohort comprised 236 379 patients diagnosed with COVID-19, and our two propensity-score-matched control cohorts comprised 105 579 patients diagnosed with influenza and 236 038 patients diagnosed with any respiratory tract infection including influenza.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plainn = 579- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For patients who had been admitted to an ITU, the estimated incidence of a diagnosis was 46·42% (44·78–48·09) and for a first diagnosis was 25·79% (23·50–28·25).”
- Also stated in: § Results · plain
“For the cohort subgroups, these estimates were 38·73% (37·87–39·60) for patients who were hospitalised, 46·42% (44·78–48·09) for those admitted to ITU, and 62·34% (60·14–64·55) for those diagnosed with encephalopathy.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Abstract > Findings
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
- Also stated in: § Results · plain
- It may state two separate claims as one. 24
- Probably not a substantial claim. 10
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most diagnostic categories were more common in patients who had COVID-19 than in those who had influenza (hazard ratio [HR] 1·44, 95% CI 1·40–1·47, for any diagnosis; 1·78, 1·68–1·89, for any first diagnosis) and those who had other respiratory tract infections (1·16, 1·14–1·17, for any diagnosis; 1·32, 1·27–1·36, for any first diagnosis).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Abstract > Findings
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
- Rests on an assumption: Propensity score matching on the measured covariates adequately controls for confounding by unmeasured factors.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“HRs were significantly greater than 1 for all diagnoses for patients who had COVID-19 compared with those who had influenza, except for parkinsonism and Guillain-Barré syndrome, and significantly greater than 1 for all diagnoses compared with patients who had respiratory tract infections (table 3).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
- Rests on an assumption: Propensity score matching on the measured covariates adequately controls for confounding by unmeasured factors.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most diagnostic categories were more common in patients who had COVID-19 than in those who had influenza (hazard ratio [HR] 1·44, 95% CI 1·40–1·47, for any diagnosis; 1·78, 1·68–1·89, for any first diagnosis) and those who had other respiratory tract infections (1·16, 1·14–1·17, for any diagnosis; 1·32, 1·27–1·36, for any first diagnosis).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Abstract > Findings
plaincorrelationaln = 379- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
- Rests on an assumption: Propensity score matching on the measured covariates adequately controls for confounding by unmeasured factors.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The COVID-19 cohort was divided into subgroups of patients who were not hospitalised (190 077 patients), those who were hospitalised (46 302 patients), those who required ITU admission (8945 patients), and those who received a diagnosis of encephalopathy (6229 patients).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plainn = 302- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The COVID-19 cohort was divided into subgroups of patients who were not hospitalised (190 077 patients), those who were hospitalised (46 302 patients), those who required ITU admission (8945 patients), and those who received a diagnosis of encephalopathy (6229 patients).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plainn = 8,945- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most diagnostic categories were more common in patients who had COVID-19 than in those who had influenza (hazard ratio [HR] 1·44, 95% CI 1·40–1·47, for any diagnosis; 1·78, 1·68–1·89, for any first diagnosis) and those who had other respiratory tract infections (1·16, 1·14–1·17, for any diagnosis; 1·32, 1·27–1·36, for any first diagnosis).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Abstract > Findings
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
- Rests on an assumption: Propensity score matching on the measured covariates adequately controls for confounding by unmeasured factors.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The COVID-19 cohort was divided into subgroups of patients who were not hospitalised (190 077 patients), those who were hospitalised (46 302 patients), those who required ITU admission (8945 patients), and those who received a diagnosis of encephalopathy (6229 patients).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plainn = 6,229- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most diagnostic categories were more common in patients who had COVID-19 than in those who had influenza (hazard ratio [HR] 1·44, 95% CI 1·40–1·47, for any diagnosis; 1·78, 1·68–1·89, for any first diagnosis) and those who had other respiratory tract infections (1·16, 1·14–1·17, for any diagnosis; 1·32, 1·27–1·36, for any first diagnosis).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Abstract > Findings
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
- Rests on an assumption: Propensity score matching on the measured covariates adequately controls for confounding by unmeasured factors.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar results were observed when patients who had COVID-19 were compared with those who had one of the four other index events (appendix pp 11–14, 34), except when an outcome had a predicted relationship with the comparator condition (eg, intracranial haemorrhage was more common in association with fracture of a large bone).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
- Rests on an assumption: The ICD-10 code U07.1 reliably identifies patients with COVID-19.
- Rests on an assumption: Propensity score matching on the measured covariates adequately controls for confounding by unmeasured factors.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The COVID-19 cohort was divided into subgroups of patients who were not hospitalised (190 077 patients), those who were hospitalised (46 302 patients), those who required ITU admission (8945 patients), and those who received a diagnosis of encephalopathy (6229 patients).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plainn = 77- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For the overall psychiatric disorder category (ICD-10 F20–48), the HR did vary with time, declining but remaining significantly higher than 1, indicating that the risk was attenuated but maintained 6 months after COVID-19 diagnosis (appendix p 9).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The timing of index events was such that most infections with influenza and many of the other respiratory tract infections occurred earlier on during the pandemic, whereas the incidence of COVID-19 diagnoses increased over time (appendix p 24).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our data provide some support for this possibility, although the incidence was low and not all HRs were significant.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
In the paper
“Whether COVID-19 is associated with Guillain-Barré syndrome remains unclear;26 our data were also equivocal, with HRs increased with COVID-19 compared with other respiratory tract infections but not with influenza (table 3), and increased compared with three of the four other index health events (appendix p 34).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
What the sources say
- Not checked yetcites [26] Keddie, 2020, Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome, Brain
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
- Rests on an assumption: The comparator cohorts (influenza and other respiratory tract infections) are appropriate to estimate the excess risk attributable to COVID-19.
None of the sources cited for this claim have been checked yet.
In the paper
“Consistent with several other reports,23, 24 the risk of cerebrovascular events (ischaemic stroke and intracranial haemorrhage) was elevated after COVID-19, with the incidence of ischaemic stroke rising to almost one in ten (or three in 100 for a first stroke) in patients with encephalopathy.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
What the sources say
- Not checked yetcites [23] Siow, 2021, Stroke as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes and predictors, J Stroke Cerebrovasc Dis source
- Not checked yetcites [24] Hernandez-Fernandez, 2020, Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description, Brain source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
None of the sources cited for this claim have been checked yet.
In the paper
“Even among patients who were hospitalised, only about 11% received this diagnosis, whereas much higher rates would be expected.18, 30”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
What the sources say
- Not checked yetcites [18] Oldham, 2020, Characterising neuropsychiatric disorders in patients with COVID-19, Lancet Psychiatry source
- Not checked yetcites [30] Docherty, 2020, Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study, BMJ
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although the estimated incidence was modest in the whole COVID-19 cohort (table 2), 2·66% of patients older than 65 years (appendix p 28) and 4·72% who had encephalopathy (table 2), received a first diagnosis of dementia within 6 months of having COVID-19.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“HRs for most neurological outcomes were constant, and hence the risks associated with COVID-19 persisted up to the 6-month timepoint.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Substance use disorders and insomnia were also more common in COVID-19 survivors than in those who had influenza or other respiratory tract infections (except for the incidence of a first diagnosis of substance use disorder after COVID-19 compared with other respiratory tract infections).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
- Rests on an assumption: The comparator cohorts (influenza and other respiratory tract infections) are appropriate to estimate the excess risk attributable to COVID-19.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The proportional hazard assumption was tested with the generalised Schoenfeld approach.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Methods > Statistical analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study was reported according to the Reporting of studies Conducted using Observational Routinely-collected health Data (RECORD, appendix pp 55–60).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Methods > Statistical analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Similar concerns have been raised regarding psychiatric sequelae of COVID-19,12, 13 with evidence showing that survivors are indeed at increased risk of mood and anxiety disorders in the 3 months after infection.14”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Introduction
What the sources say
- Not checked yetcites [14] Taquet, 2021, Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA, Lancet Psychiatry source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The only exception was for intracranial haemorrhage and ischaemic stroke in patients who had COVID-19 when compared with patients who had other respiratory tract infections (p=0·012 for intracranial haemorrhage and p=0·032 for ischaemic stroke).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Some patients in the comparison cohorts are likely to have had undiagnosed COVID-19; this would also tend to make our HRs an underestimate.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The increased rates of neurological and psychiatric sequelae were robust in all three sensitivity analyses: when patients who had died by the time of the analysis were included (appendix p 51), when the COVID-19 diagnosis was confirmed by use of an RNA or antigen test (appendix p 52), and when the sequelae were compared with those observed in patients who had influenza in 2019 or 2018 (appendix pp”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, COVID-19 was associated with increased risk of neurological and psychiatric outcomes, but the incidences and HRs of these were greater in patients who had required hospitalisation, and markedly so in those who had required ITU admission or had developed encephalopathy, even after extensive propensity score matching for other factors (eg, age or previous cerebrovascular disease).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
- Rests on an assumption: The propensity score matching adequately controls for confounding by measured covariates.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Our findings are robust given the sample size, the propensity score matching, and the results of the sensitivity and secondary analyses.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
- Rests on an assumption: The propensity score matching adequately controls for confounding by measured covariates.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, a study of this kind can only show associations; efforts to identify mechanisms and assess causality will require prospective cohort studies and additional study designs.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, as with the neurological outcomes, the psychiatric sequelae of COVID-19 appear widespread and to persist up to, and probably beyond, 6 months.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
In the paper
“Nevertheless, they have weaknesses inherent to an electronic health records study,29 such as the unknown completeness of records, no validation of diagnoses, and sparse information on socioeconomic and lifestyle factors.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
What the sources say
- Not checked yetcites [29] Casey, 2016, Using electronic health records for population health research: a review of methods and applications, Annu Rev Public Health source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The effect of these timing differences on observed rates of sequelae is unclear but, if anything, they are likely to make the HRs an underestimate because COVID-19 cases were diagnosed at a time when all other diagnoses were made at a lower rate in the population (appendix p 24).”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under-recording of delirium during acute illness is well known and probably means that the diagnosed cases had prominent or sustained features; as such, results for this group should not be generalised to all patients with COVID-19 who experience delirium.”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
The paper relies on this without support.
Diagnoses recorded in the TriNetX electronic health records accurately reflect the neurological and psychiatric outcomes under study.
“Available data include demographics, diagnoses (using codes from ICD-10), medications, procedures, and measurements (eg, blood pressure and body-mass index).”
The paper relies on this without support.
The ICD-10 code U07.1 reliably identifies patients with COVID-19.
“The primary cohort was defined as all patients who had a confirmed diagnosis of COVID-19 (ICD-10 code U07.1).”
The paper relies on this without support.
Propensity score matching on the measured covariates adequately controls for confounding by unmeasured factors.
“We used propensity score matching19 to create cohorts with matched baseline characteristics, done within the TriNetX network.”
The authors state this as an assumption.
Hospitalisation, ITU admission, and encephalopathy are valid proxies for COVID-19 severity.
“We investigated how these estimates were affected by COVID-19 severity, as proxied by hospitalisation, intensive therapy unit (ITU) admission, and encephalopathy (delirium and related disorders).”
The paper relies on this without support.
Diagnoses recorded in the electronic health records accurately reflect patients' true clinical diagnoses.
“Nevertheless, they have weaknesses inherent to an electronic health records study,29 such as the unknown completeness of records, no validation of diagnoses, and sparse information on socioeconomic and lifestyle factors.”
The paper relies on this without support.
The propensity score matching adequately controls for confounding by measured covariates.
“even after extensive propensity score matching for other factors (eg, age or previous cerebrovascular disease)”
The paper relies on this without support.
The comparator cohorts (influenza and other respiratory tract infections) are appropriate to estimate the excess risk attributable to COVID-19.
“the choice of cohorts against which to compare COVID-19 outcomes influenced the magnitude of the HRs (table 3, appendix p 34).”
The paper relies on this without support.
The 6-month follow-up period is sufficient to capture the main neurological and psychiatric outcomes of interest.
“Longer-term studies are needed to ascertain the duration of risk and the trajectory for individual diagnoses.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“compared to 24 and 25 percent of non-hospitalized, and non-ICU-treated hospitalized patients (18).”
From Cognitive Behavioral Therapy and Acceptance and Commitment Therapy (CBT-ACT) vs. Standard Care After Critical Illness Due to COVID-19: Protocol for a Pilot Randomized Controlled Trial (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“6-month prevalence of depression, mood or psychotic disorders was seen in 28 percent of ICU-treated COVID-19 patients in a recent study”
From Cognitive Behavioral Therapy and Acceptance and Commitment Therapy (CBT-ACT) vs. Standard Care After Critical Illness Due to COVID-19: Protocol for a Pilot Randomized Controlled Trial (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These issues appear to arise more frequently among COVID-19 survivors compared with other respiratory infections,9 healthcare workers or the general population3 as seen in the larger prevalence of depression, anxiety and insomnia.”
From Psychological treatments for the mental health symptoms among individuals infected with COVID-19: a scoping review protocol (2023) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Thus, although there is data pointing toward a narrow difference in mental health consequences between ICU-treated and other COVID-19 patients (18), there is still reason to believe that severity of disease in COVID-19 is associated with long-term mental health problems.”
The cited source says what the claim attributes to it.
In the citing paper
“Another study found that the hazard ratios for developing a mood or anxiety disorder in a COVID-19 recovery sample compared to people who had been infected with influenza were 1.47, p < 0.001 (1.79 for first-time mood diagnosis) and 1.45, p < 0.001 (1.78 for first-time anxiety diagnosis), respectively (Taquet et al. 2021).”
From Illness Stigma and Shame in People With Chronic Illnesses vs. SARS‐CoV‐2 Survivors: Associations With Psychological Distress Through Psychological Flexibility and Self‐Compassion. (2024) · cites this paper as Taquet et al. 2021
In the citing paper
“Taquet et al. (2021) reported a prevalence of anxiety disorder of 7.11% (95% CI = 6.82, 7.41).”
From Long-term effects of COVID-19 on mental health: a systematic review (2022) · cites this paper as Taquet et al. (2021)
In the citing paper
“Compared to clinical diagnoses reported by Taquet et al. (2021), self-reported anxiety prevalence was significantly higher, further indicating the disparities between clinical diagnosis and patient-reported screening questionnaires.”
From Long-term effects of COVID-19 on mental health: a systematic review (2022) · cites this paper as Taquet et al. (2021)
In the citing paper
“Taquet et al. (2021) reported a low prevalence of mood disorders, with other studies stating that long-term anxiety and depression in COVID-19 patients are similar to pre-pandemic levels (Klaser et al., 2021).”
From Long-term effects of COVID-19 on mental health: a systematic review (2022) · cites this paper as Taquet et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
“44 927 matched patients; matched baseline characteristics are presented in the appendix, pp 41–42”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
“COVID-19 with vs without hospitalisation (N=45 167) HR (95% CI)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
“significantly greater than 1 for all diagnoses compared with patients who had respiratory tract infections (table 3)”
§ 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records > Results
“| Substance use disorder (first) | 1·22 (1·09–1·37) | 0·0006 | 0·92 (0·86–0·99) | 0·033 |”
Citations
Cites
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242 · cited 1×
“HRs for COVID-19 diagnosis compared with the additional four index events showed more variation with time, partly reflecting the natural history of the comparator condition (appendix, pp 16–19, 36).”
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Holmes, E. A., O'Connor, R. C., Perry, V. H., Tracey, I., Wessely, S., Arseneault, L., Ballard, C., Christensen, H., Cohen Silver, R., Everall, I., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30168-1 · Cited by 5,715 · cited 5×
“Our primary cohort comprised 236 379 patients diagnosed with COVID-19, and our two propensity-score-matched control cohorts comprised 105 579 patients diagnosed with influenza and 236 038 patients diagnosed with any respiratory tract infection including influenza.”
InfluentialDocherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
COVID-19 pandemic and mental health consequences: Systematic review of the current evidence
Vindegaard, N., & Benros, M. E. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.048 · Cited by 3,221 · cited 1×
“11 Similar concerns have been raised regarding psychiatric sequelae of COVID-19, 12,13 with evidence showing that survivors are indeed at increased risk of mood and anxiety disorders in the 3 months after infection.”
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407
Neurological associations of COVID-19
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., Kneen, R., Defres, S., Sejvar, J., & Solomon, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30221-0 · Cited by 2,156
Royston, P. J., & Parmar, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1203 · Cited by 1,537 · cited 2×
“…significantly greater than 1 in this subgroup, with an overall HR for any diagnosis of 1·47 (95% CI 1·44–1·51) for patients who had COVID-19 compared with patients who had influenza, and 1·16 (1·14–1·17) compared with those who had other respiratory tract infections (table 4, appendix pp 20–21).”
Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30462-4 · Cited by 1,484
Self-citationMeinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Brünink, S., Greuel, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00758-5 · Cited by 1,458 · cited 1×
“Potential mechanisms for this association include viral invasion of the CNS, 10,11 hypercoagulable states, 22 and neural effects of the immune response.”
Cited by
Sorted by citations
Items 401–500 of 1,002
Depression and anxiety during and after episodes of COVID-19 in the community
Alacevich, C., Thalmann, I., Nicodemo, C., de Lusignan, S., & Petrou, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-33642-w · Cited by 32
Ge, M., Tian, Y., & Ge, Y. (2021) · Computer-Aided Design and Applications · doi:10.14733/cadaps.2022.s3.153-163 · Cited by 29
Brain exposure to SARS-CoV-2 virions perturbs synaptic homeostasis
Partiot, E., Hirschler, A., Colomb, S., Lutz, W., Claeys, T., Delalande, F., Deffieu, M. S., Bare, Y., Roels, J. R. E., Gorda, B., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01657-2 · Cited by 33
Zhao, J., Xia, F., Jiao, X., & Lyu, X. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1367974 · Cited by 31
Yang, J. Y., Li, H., Zhao, H., Xie, Y., Li, J., & Wang, M. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-074325 · Cited by 31
Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes
Colbourne, L., Luciano, S., & Harrison, P. J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01444-1 · Cited by 29
Self-citationCognitive impairment and functional change in COVID-19 patients undergoing inpatient rehabilitation
Patel, R., Savrides, I., Cahalan, C., Doulatani, G., O’Dell, M. W., Toglia, J. P., & Jaywant, A. (2021) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0000000000000483 · Cited by 31
COVID-19 and male reproductive system: pathogenic features and possible mechanisms
Zadeh, A. A., & Arab, D. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-021-10003-3 · Cited by 32
The COVID-19 pandemic: an opportunity to make mental health a higher public health priority
Latoo, J., Haddad, P. M., Mistry, M., Wadoo, O., Islam, S. M. S., Jan, F., Iqbal, Y., Howseman, T., Riley, D., & Alabdulla, M. (2021) · BJPsych Open · doi:10.1192/bjo.2021.1002 · Cited by 28
Giryes, S., Bragazzi, N. L., Bridgewood, C., Marco, G. D., & McGonagle, D. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00928-6 · Cited by 32
Yehia, A., & Abulseoud, O. A. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00728-6 · Cited by 35
SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022
Miller, M. G., Terebuh, P., Kaelber, D. C., Xu, R., & Davis, P. B. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.39444 · Cited by 29
Griffanti, L., Raman, B., Alfaro‐Almagro, F., Filippini, N., Cassar, M. P., Sheerin, F., Okell, T. W., McConnell, F. A. K., Chappell, M. A., Wang, C., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.753284 · Cited by 28
Association between serum lithium level and incidence of COVID-19 infection
Picker, L. D., Leboyer, M., Geddes, J., et al. (2022) · The British Journal of Psychiatry · doi:10.1192/bjp.2022.42 · Cited by 28
Self-citationPalladini, M., Bravi, B., Colombo, F., Caselani, E., Pasquasio, C. D., D'Orsi, G., Rovere, P. Q., Poletti, S., Benedetti, F., & Mazza, M. G. (2022) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2022.2075016 · Cited by 32
Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication
Thiele, I., & Fleming, R. M. T. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.019 · Cited by 22
Predictors of “brain fog” 1 year after COVID-19 disease
Cristillo, V., Pilotto, A., Piccinelli, S. C., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06285-4 · Cited by 28
Post-acute sequelae of COVID-19 in older persons: multi-organ complications and mortality
Wan, E. Y. F., Zhang, R., Mathur, S., Yan, V. K. C., Lai, F. T. T., Chui, C. S. L., Li, X., Wong, C. K. H., Chan, E. W., Lau, C. S., et al. (2023) · Journal of Travel Medicine · doi:10.1093/jtm/taad082 · Cited by 30
Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response
Mohan, A., Iyer, V. A., Kumar, D., Batra, L., & Dahiya, P. (2023) · Life · doi:10.3390/life13112121 · Cited by 31
Long COVID: Long-Term Impact of SARS-CoV2
Makhluf, H. A., Madany, H., & Kim, K. (2024) · Diagnostics · doi:10.3390/diagnostics14070711 · Cited by 28
Al‐Hakeim, H. K., Al-Rubaye, H. T., Al-Hadrawi, D. S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1610917/v1 · Cited by 28
Izquierdo‐Condoy, J. S., Vasconez-Gonzáles, J., Morales-Lapo, E., Tello-De-la-Torre, A., Naranjo-Lara, P., Fernández, R., Hidalgo, M. R., Escobar, A., Yépez, V. H., Díaz, A. M., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1293782 · Cited by 28
Jiang, Y., Neal, J., Sompol, P. M., Yener, G., Arakaki, X., Norris, C. M., Farina, F. R., Ibáñez, A. M., Lopez, S., Al‐Ezzi, A. A. A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14089 · Cited by 25
Peramo-Álvarez, F. P., Zúñiga, M. Á. L., & López‐Ruz, M. Á. (2021) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2021.04.008 · Cited by 30
Models of Care for Postacute COVID-19 Clinics
Verduzco‐Gutierrez, M., Estores, I. M., Graf, M. J. P., Barshikar, S., Cabrera, J. A., Chang, L. E., Eapen, B. C., & Bell, K. R. (2021) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001892 · Cited by 27
Whiteside, D. M., Naini, S. M., Basso, M. R., Waldron, E. J., Holker, E. G., Porter, J. N., Niskanen, N., Melnik, T. E., & Taylor, S. E. (2022) · The Clinical Neuropsychologist · doi:10.1080/13854046.2022.2030411 · Cited by 27
Larson, P. S., & Bergmans, R. S. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100218 · Cited by 26
Woodward, S., Bari, S., Vike, N. L., Lalvani, S., Stetsiv, K., Kim, B. W., Stefanopoulos, L., Maglaveras, N., Breiter, H. C., & Katsaggelos, A. K. (2022) · JMIR Formative Research · doi:10.2196/36656 · Cited by 31
de Erausquin, G. A., Snyder, H. M., Brugha, T. S., Seshadri, S. S., Carrillo, M. C., Sagar, R., Huang, Y., Newton, C. R. J. C., Tartaglia, M. C., Teunissen, C. E., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12348 · Cited by 27
Scurati, R., Papini, N., Giussani, P., Alberti, G., & Tringali, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012311 · Cited by 31
Davé, V. A., & Klein, R. S. (2023) · Glia · doi:10.1002/glia.24294 · Cited by 29
Agergaard, J., Khan, B. Y. A., Engell-Sørensen, T., Schiøttz‐Christensen, B., Østergaard, L. J., Hejbøl, E. K., Schrøder, H. D., Andersen, H., Blicher, J. U., Pedersen, T. H., et al. (2023) · Clinical Neurophysiology · doi:10.1016/j.clinph.2023.01.010 · Cited by 29
Salfi, F., Amicucci, G., Corigliano, D., Viselli, L., D’Atri, A., Tempesta, D., & Ferrara, M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.010 · Cited by 26
Bhola, S., Trisal, J., Thakur, V., Kaur, P., Kulshrestha, S., Bhatia, S. K., & Kumar, P. (2022) · Neurological Sciences · doi:10.1007/s10072-022-05875-6 · Cited by 42
Loft, M. I., Foged, E. M., & Koreska, M. (2022) · Qualitative Health Research · doi:10.1177/10497323221099467 · Cited by 27
Salci, M. A., Carreira, L., Facchini, L. A., de Oliveira, M. L. F., de Oliveira, R. R., Ichisato, S. M. T., Covre, E. R., Pesce, G. B., Santos, J. A. T., Derhun, F. M., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061094 · Cited by 32
Memory alterations after COVID-19 infection: a systematic review
Llana, T., Zorzo, C., Méndez-López, M., & Méndez, M. (2022) · Applied Neuropsychology Adult · doi:10.1080/23279095.2022.2123739 · Cited by 26
Almulla, A. F., Al‐Hakeim, H. K., & Maes, M. H. J. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13514 · Cited by 26
COVID-19 and New-Onset Psychosis: A Comprehensive Review
Moccia, L., Kotzalidis, G. D., Bartolucci, G., Ruggiero, S., Monti, L., Biscosi, M., Terenzi, B., Ferrara, O. M., Mazza, M., Nicola, M. D., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13010104 · Cited by 26
Otani, K., Fukushima, H., & Matsuishi, K. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100074 · Cited by 25
Memory, Emotion, and Quality of Life in Patients with Long COVID-19
Herranz, K. E., Delgado‐Lima, A. H., Villatoro, B. S., Garaboa, E. M., Gómez, V. S., Vides, L. I. G., Bouhaben, J., & Delgado‐Losada, M. L. (2023) · Brain Sciences · doi:10.3390/brainsci13121670 · Cited by 28
Rong, Z., Mai, H., Kapoor, S., Puelles, V. G., Czogalla, J., Schädler, J., Vering, J., Delbridge, C., Steinke, H., Frenzel, H., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.04.535604 · Cited by 26
Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach
Griffin, D. O. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae462 · Cited by 29
Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19
Khwatenge, C. N., Pate, M., Miller, L. C., & Sang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732913 · Cited by 22
Systemic inflammation and emotional responses during the COVID-19 pandemic
Hamilton, O. S., Cadar, D., & Steptoe, A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01753-5 · Cited by 24
Chuang, H., Hsiao, M., Wang, T., & Liang, H. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.02.002 · Cited by 24
Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity
Lipman, D., Safo, S. E., & Chekouo, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267047 · Cited by 22
Potential Factors That Contribute to Post-COVID-19 Fatigue in Women
Rudroff, T., Workman, C. D., & Bryant, A. (2022) · Brain Sciences · doi:10.3390/brainsci12050556 · Cited by 25
Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients
Michael, B. D., Walton, D., Westenberg, E., García‐Azorín, D., Singh, B., Tamborska, A., Netravathi, M., Chomba, M., Wood, G. K., Easton, A., et al. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22010002 · Cited by 26
Safety of COVID-19 Vaccines: Spotlight on Neurological Complications
Tondo, G., Virgilio, E., Naldi, A., Bianchi, A., & Comi, C. (2022) · Life · doi:10.3390/life12091338 · Cited by 26
Pearson, M., Singh, P., Bartel, H., Crawford, P., & Allsopp, G. M. (2022) · Health Expectations · doi:10.1111/hex.13602 · Cited by 27
Alvarez, M., Trent, E., Gonçalves, B. D. S., Pereira, D. G., Puri, R., Frazier, N. A., Sodhi, K., & Pillai, S. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1020092 · Cited by 24
Tisler, A., Stirrup, O., Pisarev, H., Kalda, R., Meister, T., Suija, K., Kolde, R., Piirsoo, M., & Uusküla, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278057 · Cited by 23
The functional and structural changes in the hippocampus of COVID-19 patients
Nouraeinejad, A. (2023) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02291-1 · Cited by 28
Marchesan, J. T., Warner, B. M., & Byrd, K. M. (2021) · Journal of Periodontology · doi:10.1002/jper.21-0277 · Cited by 23
Knapp, S. A. B., Austin, D. S., Aita, S. L., Caron, J. E., Owen, T., Borgogna, N. C., Bene, V. A. D., Roth, R. M., Milberg, W., & Hill, B. D. (2024) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2024-333950 · Cited by 26
Szewczyk, W., Fitzpatrick, A. L., Fossou, H., Gentile, N. L., Sotoodehnia, N., Vora, S. B., West, T. E., Bertolli, J., Cope, J. R., Lin, J.-M. S., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10158-w · Cited by 31
Li, X., Edén, A., Malwade, S., Cunningham, J. L., Bergquist, J., Weidenfors, J. A., Sellgren, C. M., Engberg, G., Piehl, F., Gisslén, M., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.031 · Cited by 24
bidhendi-Yarandi, R., Biglarian, A., Karlstad, J., Moe, C. F., Bakhshi, E., khodaei-Ardakani, M., & Behboudi-Gandevani, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0312351 · Cited by 23
The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis—A Preliminary Report
Satheesh, N. J., Salloum‐Asfar, S., & Abdulla, S. A. (2021) · Viruses · doi:10.3390/v13102091 · Cited by 24
Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses
Lam, S. M., Huang, X., & Shui, G. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.04.011 · Cited by 25
Castro, V. M., Rosand, J. M., Giacino, J. T., McCoy, T. H., & Perlis, R. H. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01646-z · Cited by 22
Hazumi, M., Usuda, K., Okazaki, E., Kataoka, M., & Nishi, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811316 · Cited by 23
Kuanr, M., Mohapatra, P., Mittal, S., Maindarkar, M. A., Fouda, M. M., Saba, L., Saxena, S., & Suri, J. S. (2022) · Diagnostics · doi:10.3390/diagnostics12112700 · Cited by 25
Human brain organoids to explore SARS‐CoV‐2‐induced effects on the central nervous system
Ostermann, P. N., & Schaal, H. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2430 · Cited by 23
Schuch, H. S., Cademartori, M. G., Dias, V. D., Levandowski, M. L., Munhoz, T. N., Hallal, P. C., & Demarco, F. F. (2023) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202320220100 · Cited by 26
Long COVID and possible preventive options
Sebők, S., & Gyires, K. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01204-1 · Cited by 24
Boito, D., Eklund, A., Tisell, A., Levi, R., Özarslan, E., & Blystad, I. (2023) · Brain Communications · doi:10.1093/braincomms/fcad284 · Cited by 26
Beyond the acute illness: Exploring long COVID and its impact on multiple organ systems
Bhattacharjee, N., Sarkar, P., & Sarkar, T. (2023) · Physiology International · doi:10.1556/2060.2023.00256 · Cited by 24
Duindam, H. B., Mengel, D., Kox, M., Göpfert, J. C., Kessels, R. P. C., Synofzik, M., Pickkers, P., & Abdo, W. F. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.002 · Cited by 27
Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome
Anand, H., Ende, V., Singh, G. K., Qureshi, I., Duong, T. Q., & Mehler, M. F. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.727060 · Cited by 22
Qureshi, A. I., Baskett, W. I., Huang, W., Naqvi, S. H., & Shyu, C.-R. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac115 · Cited by 23
Kausel, L., Figueroa-Vargas, A., Zamorano, F. J., Stecher, X., Aspé-Sánchez, M., Carvajal-Paredes, P., Márquez-Rodríguez, V., Martínez-Molina, M. P., Román, C., Soto-Fernández, P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69772-y · Cited by 24
COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People
Walker, V. M., Patalay, P., Coronado, J. I. C., Denholm, R., Forbes, H. J., Stafford, J., Moltrecht, B., Palmer, T., Walker, A. J., Thompson, E. J., et al. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.2339 · Cited by 23
Xu, C., & Zhai, Y. (2021) · Computer-Aided Design and Applications · doi:10.14733/cadaps.2022.s3.119-129 · Cited by 23
Dong, J., Yang, C. H., Ding, H.-Q., Xing, P., Zhou, F.-Y., Tian, H., Liu, X., Zheng, H., Hu, S., & Zhu, Z. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03133 · Cited by 24
Carod-Artal, F. J., & García‐Moncó, J. C. (2021) · Neurology Perspectives · doi:10.1016/j.neurop.2021.07.005 · Cited by 24
Pulmonary Complications after COVID-19
Jakubec, P., Fišerová, K., Genzor, S., & Kolář, M. (2022) · Life · doi:10.3390/life12030357 · Cited by 27
Fujii, R., Konno, Y., Tateishi, S., Hino, A., Tsuji, M., Ikegami, K., Nagata, M., Yoshimura, R., Matsuda, S., Fujino, Y., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.786400 · Cited by 25
Busatto, G. F., de Araújo, A. L., Castaldelli-Maia, J. M., Damiano, R. F., Imamura, M., Guedes, B. F., Pinna, F. R., Sawamura, M. V. Y., Mancini, M. C., da Silva, K. R., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722001374 · Cited by 25
Gestational immune activation disrupts hypothalamic neurocircuits of maternal care behavior
Zambon, A., Rico, L. C., Herman, M., Gundacker, A., Telalovic, A., Hartenberger, L.-M., Kuehn, R., Romanov, R. A., Hussaini, S. A., Harkany, T., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01602-x · Cited by 21
Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity
Ford, B. N., & Savitz, J. B. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00288-7 · Cited by 18
Mitophagy in the aging nervous system
Rappe, A., & McWilliams, T. G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.978142 · Cited by 22
Thungana, Y., Wilkinson, R. J., & Zingela, Z. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058013 · Cited by 23
Long-term outcomes of COVID-19 convalescents: An 18.5-month longitudinal study in Wuhan
Guo, Y., Wang, H., Xiao, M., Guan, X., Lei, Y., Diao, T., Long, P., Zeng, R., Lai, X., Cai, H., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.12.008 · Cited by 23
Amyloid Protein Cross-Seeding Provides a New Perspective on Multiple Diseases In Vivo
Ge, W., Deng, X., Shi, W., Lin, W.-J., Chen, L., Liang, H., Wang, X., Zhang, T., Zhao, F., Guo, W., et al. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c01233 · Cited by 24
Imaging and neuropathological findings in patients with Post COVID-19 Neurological Syndrome—A review
Okrzeja, J., Garkowski, A., Kubas, B., & Moniuszko-Malinowska, A. M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1136348 · Cited by 23
Stüdle, C., Nishihara, H., Wischnewski, S., Kulsvehagen, L., Perriot, S., Ishikawa, H., Schroten, H., Frank, S., Deigendesch, N., Pasquier, R. D., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00479-4 · Cited by 24
The association of insomnia with long COVID: An international collaborative study (ICOSS-II)
Chen, S., Morin, C. M., Ivers, H., Wing, Y. K., Partinen, M., Merikanto, I., Holzinger, B., Espie, C. A., Gennaro, L. D., Dauvilliers, Y. A., et al. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.09.034 · Cited by 22
The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems
Golzardi, M., Hromić‐Jahjefendić, A., Šutković, J., Aydın, O., Ünal‐Aydın, P., Bećirević, T., Redwan, E. M. M. M., Rubio‐Casillas, A., & Uversky, V. N. (2024) · Biomedicines · doi:10.3390/biomedicines12040913 · Cited by 29
Online Mental Health Assessments of COVID-19 Patients in South Korea
Lee, J. H., Lee, D., Hyun, S. Y., Hong, J. S., Kim, C., Kim, W., & Sim, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.685445 · Cited by 24
Incident autoimmune diseases in association with a SARS-CoV-2 infection: A matched cohort studyPreprint
Tesch, F., Ehm, F., Vivirito, A., et al. (2023) · medRxiv · doi:10.1101/2023.01.25.23285014 · Cited by 23
Chen, Y., Drye, M., Chen, Q., Fecher, M., Liu, G., & Guthrie, W. (2023) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2023.113514 · Cited by 25
A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers
Chen, X., Gao, W., Li, J., You, D., Yu, Z., Zhang, M., Shao, F., Wei, Y., Zhang, R., Lange, T., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab206 · Cited by 20
Emerging Knowledge of the Neurobiology of COVID-19
Butler, M., Cross, B., Hafeez, D., Lim, M. F., Morrin, H., Rengasamy, E. R., Pollak, T. A., & Nicholson, T. R. (2021) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2021.11.001 · Cited by 20
Gimbrone, C., Rutherford, C. G., Kandula, S., Martínez‐Alés, G., Shaman, J. L., Olfson, M., Gould, M. S., Pei, S., Galanti, M., & Keyes, K. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260931 · Cited by 22
Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study
Rocha‐Filho, P. A. S., Magalhães, J. E., Silva, D. F., Soares, M. C., Buarque, L. M. D. A., Gama, M. D. P., & de Oliveira, F. A. A. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-021-01851-7 · Cited by 23
Assessment and Management of Long COVID
Rivas-Vazquez, R. A., Rey, G. J. F. D., Quintana, A., & Rivas-Vazquez, A. A. (2022) · Journal of Health Service Psychology · doi:10.1007/s42843-022-00055-8 · Cited by 23
Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
Latorre, D. (2022) · European Journal of Immunology · doi:10.1002/eji.202149475 · Cited by 20
Mitra, J., Kodavati, M. M., Provasek, V. E., Rao, K. S. J., MITRA, S. P., Hamilton, D. J., Horner, P. J., Vahidy, F., Britz, G. W., Kent, T. A., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101687 · Cited by 20
Metadata
- Authors
- Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J.
- Affiliations
- Oxford Health NHS Foundation Trust (GB)
- TriNetX (United States) (US)
- Corresponding author
- Harrison, Paul J
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 8
- Issue
- 5
- Pages
- 416-427
- ISSN
- 2215-0366 (ISSN-L)
- PMC
- PMC8023694
- OpenAlex
- W3148333766
- Semantic Scholar
- 81d0f9614f3454de7682cc062b48e04d82329866
- Cited by
- 2,189
- References
- 35
- Citations by year
- 2026: 137 · 2025: 186 · 2024: 346 · 2023: 467 · 2022: 640 · 2021: 408
- FWCI
- 222.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Psychiatry (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- NIHR
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- COVID-19 pandemic, neurological sequelae, psychiatric sequelae, long COVID, incidence, respiratory infections, stroke, dementia, psychosis, anxiety disorders, substance use disorders, insomnia, Guillain-Barré syndrome, parkinsonism, encephalitis, delirium, COVID-19 severity, hospitalization, intensive care unit admission
- MeSH terms
- COVID-19, SARS-CoV-2, Mental Disorders, Female, Humans, Influenza, Human, Male, Middle Aged, Nervous System Diseases, Outcome and Process Assessment, Health Care, Research Design, Respiratory Tract Infections, Risk Factors, Severity of Illness Index, Global Health, Cohort Studies, Incidence, Proportional Hazards Models, Risk Assessment, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
